https://www.avient.com/company/policies-and-governance/global-policy-antitrust
Global ISO Certificate Library
https://www.avient.com/company/purpose-strategic-framework
Global ISO Certificate Library
https://www.avient.com/company/policies-and-governance/ethics-hotline
Global ISO Certificate Library
https://www.avient.com/company/sustainability/performance/report-archive
Global ISO Certificate Library
https://www.avient.com/company/policies-and-governance-0/code-conduct
Global ISO Certificate Library
https://www.avient.com/company/sustainability/planet/responsible-care
Global ISO Certificate Library
https://www.avient.com/news/avient-introduces-low-shrinkage-alternative-abs-luxury-packaging-market
POMMERLOCH, Luxembourg – March 21, 2024 – Avient Corporation, a premier provider of specialized and sustainable materials solutions and services, today announced the introduction of new Gravi-Tech™ Density Modified Formulation grades with low shrinkage, offering luxury packaging customers an alternative to acrylonitrile butadiene styrene (ABS) based materials.
https://www.avient.com/news/new-lsfoh-formulation-avient-helps-prevent-environmental-stress-cracking-armored-cables
POMMERLOCH, Luxembourg – December 11, 2023 – Avient Corporation, a premier provider of specialized and sustainable material solutions and services, today announced the addition of a new grade to its ECCOH™ Low Smoke and Fume Non-Halogen Formulations portfolio.
https://www.avient.com/news/avient-extends-bio-based-polyolefin-range-utilizing-benefits-cellulose-fiber
POMMERLOCH, Luxembourg – February 7, 2023 – Today, Avient Corporation announced an expansion to its portfolio of Maxxam™ BIO bio-based polyolefins, strengthening its commitment to provide more sustainable solutions.
https://www.avient.com/news/avient-and-ivcc-accelerate-formulation-development-long-lasting-insecticidal-nets-malaria-control
POMMERLOCH, Luxembourg – April 23, 2021 – According to the World Health Organization, every year there are more than 200 million new cases of malaria, with children under 5 the most vulnerable group affected by the disease.
